Bayer AG Receives “Hold” Rating from Independent Research GmbH (BAYN)

Independent Research GmbH reissued their hold rating on shares of Bayer AG (FRA: BAYN) in a research note released on Friday morning, ARN reports. They currently have a €88.00 ($114.29) target price on the stock.

Bayer AG (FRA: BAYN) traded up 2.28% on Friday, hitting €86.598. Bayer AG has a 1-year low of €47.68 and a 1-year high of €85.64. The stock’s 50-day moving average is currently €0..

A number of other firms have also recently commented on BAYN. Analysts at Morgan Stanley initiated coverage on shares of Bayer AG in a research note to investors on Thursday, May 23rd. They set an equal weight rating and a €93.00 ($120.78) price target on the stock. Separately, analysts at BNP Paribas reiterated a neutral rating on shares of Bayer AG in a research note to investors on Thursday, May 23rd. They now have a €76.00 ($98.70) price target on the stock. Finally, analysts at Sanford C. Bernstein reiterated a market perform rating on shares of Bayer AG in a research note to investors on Friday, May 17th. They now have a €75.00 ($97.40) price target on the stock.

Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of Hold and a consensus price target of €79.64 ($103.43).

.

Latest News

$160.07 Million in Sales Expected for Docusign Inc  This Quarter
$160.07 Million in Sales Expected for Docusign Inc This Quarter
Dassault Systemes SE  Receives Consensus Rating of “Hold” from Brokerages
Dassault Systemes SE Receives Consensus Rating of “Hold” from Brokerages
Atkore International Group Inc  Receives Consensus Rating of “Buy” from Brokerages
Atkore International Group Inc Receives Consensus Rating of “Buy” from Brokerages
Brokerages Expect Sprint Corp  to Announce $0.01 Earnings Per Share
Brokerages Expect Sprint Corp to Announce $0.01 Earnings Per Share
CymaBay Therapeutics Inc  Receives $19.00 Average Price Target from Analysts
CymaBay Therapeutics Inc Receives $19.00 Average Price Target from Analysts
Zonecoin Achieves Market Capitalization of $25,297.00
Zonecoin Achieves Market Capitalization of $25,297.00


© 2006-2018 Ticker Report. Google+.